首页/数据集/Supplementary Data from Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis

Supplementary Data from Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis

NIAID Data Ecosystem2026-05-01 收录

HPV致癌机制

宫颈癌分子病理

数据链接：

https://figshare.com/articles/dataset/Supplementary_Data_from_Extrachromosomal_Amplification_of_Human_Papillomavirus_Episomes_Is_a_Mechanism_of_Cervical_Carcinogenesis/30699808 数据链接链接失效反馈

官方服务：

资源简介：

Supplemental tables

应用场景：

创建时间：

2023-06-02

HPV致癌机制

基因表达调控

To investigate the extent of gene expression dysregulation by the human papillomavirus (HPV) oncoprotein E7, we performed global gene expression analysis on normal immortalized keratinocytes from skin

NIAID Data Ecosystem70

LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells. LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells

lncRNA功能机制

宫颈癌分子病理

Long non-coding RNAs (lncRNAs) have been extensively studied as key regulators of cancer development in various cancers. TP53TG1 is a newly identified lncRNA in recent years, and several studies have

NIAID Data Ecosystem60

Identification of deregulated pathways, key regulators, and novel miRNA-mRNA interactions in HPV-mediated transformation. [CGH cell lines-Agilent]. Identification of deregulated pathways, key regulators, and novel miRNA-mRNA interactions in HPV-mediated transformation. [CGH cell lines-Agilent]

HPV致癌机制

分子生物学

Next to a persistent infection with high-risk human papillomavirus (HPV), molecular changes are required for the development of cervical cancer. To identify which molecular alterations drive carcinoge

NIAID Data Ecosystem30

In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction

HPV致癌机制

乳腺癌早期发生

High prevalence of infection with high-risk human papilloma virus (HPV) ranging from 25 to 100% (average 31%) was observed in breast cancer (BC) patients in Singapore using novel DNA chip technology.

NIAID Data Ecosystem60

Human HPV16 positive CaSki cells: Control vs. virus oncogene e6/e7 silenced

HPV致癌机制

肿瘤基因功能验证

Human HPV16 positive CaSki cells: Control vs. virus oncogene e6/e7 silenced

ChEBI2016-07-01 更新40